Cushman & Wakefield plc (CWK)
Official siteREAL ESTATE • REAL ESTATE SERVICES • NYSE
Market Cap: $3.12B
Last updated: Nov 17, 2026 at 11:04 AM ET
Cushman & Wakefield plc (CWK) Stock Forecast
Analysts expect Cushman & Wakefield (CWK) to earn $1.47 per share in the fiscal year ending Dec 31, 2026, on revenue of $11.16B. Of 12 analysts, 7 rate the stock Buy or Strong Buy, 5 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 4 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 2.17, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 58% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 25.0% |
| Buy | 4 | 33.3% |
| Hold | 5 | 41.7% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 12
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 15.0% and revenue estimates rise 5.9%.
- Fiscal year ending Dec 31, 2026
- $1.47
- EPS consensus, revenue $11.16B
- Fiscal year ending Dec 31, 2027
- $1.69
- EPS consensus, revenue $11.82B
- Next report
- Feb 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.47 | $1.43 to $1.48 | 12 | $11.16B | $11.05B to $11.28B | 8 |
| Dec 31, 2027 | $1.69 | $1.51 to $1.88 | 12 | $11.82B | $11.64B to $12.06B | 8 |
Quarterly Estimates
The EPS consensus falls from $0.60 for the quarter ending Dec 31, 2026 to $0.18 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.60 | $0.57 to $0.64 | 11 | $3.04B | $2.89B to $3.23B | 9 |
| Mar 31, 2027 | $0.18 | $0.12 to $0.29 | 7 | $2.66B | $2.63B to $2.71B | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 14 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 4 |
| Fiscal year ending Dec 31, 2027 | 1 | 6 |
| Quarter ending Mar 31, 2027 | 0 | 4 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 is where it was 90 days ago.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $1.47 | $1.46 | $1.47 | $1.47 | $1.47 | 0.0% |
| Fiscal year ending Dec 31, 2027 | $1.69 | $1.68 | $1.72 | $1.72 | $1.72 | -1.8% |
| Quarter ending Mar 31, 2027 | $0.18 | $0.14 | $0.15 | $0.16 | $0.15 | +18.6% |
Frequently Asked Questions About CWK
What is the CWK stock forecast?
Consensus analyst estimates put Cushman & Wakefield's EPS at $1.47 for the fiscal year ending Dec 31, 2026, on revenue of $11.16B. The consensus rating from 12 analysts is Buy.
How do analysts rate CWK stock?
Of 12 analysts covering Cushman & Wakefield, 3 rate it Strong Buy, 4 Buy, 5 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from CWK next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $1.47, with estimates from $1.43 to $1.48 from 12 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.69, with estimates from $1.51 to $1.88 from 12 analysts.
What revenue do analysts expect from Cushman & Wakefield next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $11.16B, with estimates from $11.05B to $11.28B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $11.82B, with estimates from $11.64B to $12.06B.
How many analysts cover CWK?
12 analysts rate Cushman & Wakefield stock, and 12 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CWK pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts